Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates

Assembly and Immunological Processing of Polyelectrolyte Multilayers Composed of Antigens and Adjuvants

(2016) Yu-Chieh Chiu et al.   ACS Applied Materials & Interfaces

Improving the clinical impact of biomaterials in cancer immunotherapy

(2016) Joshua M. Gammon et al.   Oncotarget

Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response

(2015) Peipei Zhang et al.   ACS Nano

Initial design and physical characterization of a polymeric device for osmosis-driven delayed burst delivery of vaccines

(2015) Ferry P.W. Melchels et al.   BIOTECHNOLOGY AND BIOENGINEERING

Effect of vaccine administration modality on immunogenicity and efficacy

(2015) Lu Zhang et al.   Expert Review of Vaccines

Modular Vaccine Design Using Carrier-Free Capsules Assembled from Polyionic Immune Signals

(2015) Yu-Chieh Chiu et al.   ACS Biomaterials-Science & Engineering

Modular Vaccine Design Using Carrier-Free Capsules Assembled from Polyionic Immune Signals

(2015) Yu-Chieh Chiu et al.   ACS Biomaterials Science & Engineering

Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance

(2014) James I. Andorko et al.   AAPS Journal

Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity

(2014) Vincent Pavot et al.   JOURNAL OF IMMUNOLOGY

Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy

(2014) Paul T. Bremer et al.   MOLECULAR PHARMACEUTICS

Rational design of small molecules as vaccine adjuvants

(2014) T. Y.- H. Wu et al.   Science Translational Medicine

Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo

(2013) Kenichi Niikura et al.   ACS Nano

Covalent modification of cell surfaces with TLR agonists improves & directs immune stimulation

(2013) Janine K. Tom et al.   CHEMICAL COMMUNICATIONS

Recent progress concerning CpG DNA and its use as a vaccine adjuvant

(2013) Hidekazu Shirota et al.   Expert Review of Vaccines

The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells

(2013) William R Heath et al.   NATURE IMMUNOLOGY

Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant

(2013) Fangjia Lu et al.   VACCINE

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

(2012) Che-Ming Jack Hu et al.   BIOCHEMICAL PHARMACOLOGY

Vaccine process technology

(2012) Jessica O. Josefsberg et al.   BIOTECHNOLOGY AND BIOENGINEERING

Nanoparticle Hydrophobicity Dictates Immune Response

(2012) Daniel F. Moyano et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Engineering Approaches to Immunotherapy

(2012) M. A. Swartz et al.   Science Translational Medicine

Programming the magnitude and persistence of antibody responses with innate immunity

(2011) Sudhir Pai Kasturi et al.   NATURE

New insights in mucosal vaccine development

(2011) Vincent Pavot et al.   VACCINE

Use of defined TLR ligands as adjuvants within human vaccines

(2010) Malcolm S. Duthie et al.   IMMUNOLOGICAL REVIEWS

Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice

(2010) Qing Zhu et al.   JOURNAL OF CLINICAL INVESTIGATION

TLR-based immune adjuvants

(2010) Folkert Steinhagen et al.   VACCINE

Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes

(2009) Rafael Cubas et al.   JOURNAL OF IMMUNOTHERAPY